emtricitabine
PolandDrugs containing this active substance
-
This medicine is used in adult patients (18 years and older) with human immunodeficiency virus type 1 (HIV-1) infection, where previous antiretroviral therapy has not failed and the infection has been controlled for at least three months.
Form: tablets, film-coated
Active substance Dosage efavirenz 600 mg emtricitabine 200 mg tenofovir disoproxil 245 mg ATC: J05AR06
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmaceutica, S.A.
-
The medicinal product is used in adults and adolescents (from 12 to 18 years of age weighing at least 35 kg) for the treatment of HIV-1 infection. It may also be used to reduce the risk of HIV infection in adults and adolescents aged 12 to 18 years (weighing at least 35 kg), provided it is taken daily in conjunction with safe sex practices.
Form: tablets, film-coated
Active substance Dosage emtricitabine 200 mg tenofovir disoproxil 245 mg ATC: J05AR03
Manufacturer: APL Swift Services (Malta) Ltd. Generis Farmaceutica, S.A.
-
The medicinal product is used in adults and adolescents (from 12 to 18 years of age weighing at least 35 kg) for the treatment of HIV-1 infection. It may also be used to reduce the risk of HIV-1 infection in adults and adolescents meeting the above criteria, provided it is taken daily in conjunction with safe sex practices.
Form: tablets, film-coated
Active substance Dosage emtricitabine 200 mg tenofovir disoproxil 245 mg ATC: J05AR03
Manufacturer: Tillomed Malta Limited